PubRank

Beth A Drolet

Author PubWeight™ 61.59‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 De novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromes. Nat Genet 2012 4.51
2 Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon. Pediatr Blood Cancer 2012 2.29
3 Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006 2.28
4 Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007 1.96
5 Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008 1.95
6 Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA. Pediatr Dermatol 2005 1.77
7 Risk for PHACE syndrome in infants with large facial hemangiomas. Pediatrics 2010 1.60
8 Linear scleroderma en coup de sabre with associated neurologic abnormalities. Pediatrics 2005 1.43
9 Retrospective review of adverse effects from propranolol in infants. JAMA Dermatol 2013 1.40
10 The Cyrano nose: refinements in surgical technique and treatment approach to hemangiomas of the nasal tip. Plast Reconstr Surg 2010 1.39
11 Hypoglycemia in children taking propranolol for the treatment of infantile hemangioma. Arch Dermatol 2010 1.38
12 Pulmonary thromboembolism associated with Klippel-Trenaunay syndrome. Pediatrics 2005 1.28
13 Lichenoid eruptions in children. J Am Acad Dermatol 2004 1.20
14 Cutaneous manifestations of hemophagocytic lymphohistiocytosis. Arch Dermatol 2002 1.17
15 Multicenter prospective study of ulcerated hemangiomas. J Pediatr 2007 1.15
16 Congenital dermatofibrosarcoma protuberans: variability in presentation. Arch Dermatol 2003 1.14
17 Propranolol for infantile hemangiomas: promise, peril, pathogenesis. Pediatr Dermatol 2009 1.05
18 Vesicular eczema after intravenous immunoglobulin therapy for treatment of Stevens-Johnson syndrome. Arch Dermatol 2006 1.04
19 PHACE syndrome: current knowledge, future directions. Pediatr Dermatol 2009 0.98
20 Medical management of tumors associated with Kasabach-Merritt phenomenon: an expert survey. J Pediatr Hematol Oncol 2013 0.97
21 Skin lesions in the neonate. Pediatr Clin North Am 2004 0.96
22 Comparison of infantile hemangiomas in preterm and term infants: a prospective study. Arch Dermatol 2008 0.95
23 Stroke in children with posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of the aorta and cardiac defects, and eye abnormalities (PHACE) syndrome: a systematic review of the literature. Stroke 2012 0.95
24 Serum 25-hydroxyvitamin D concentration does not correlate with atopic dermatitis severity. J Am Acad Dermatol 2013 0.94
25 Congenital cardiac, aortic arch, and vascular bed anomalies in PHACE syndrome (from the International PHACE Syndrome Registry). Am J Cardiol 2013 0.93
26 Clinical spectrum and risk of PHACE syndrome in cutaneous and airway hemangiomas. Arch Otolaryngol Head Neck Surg 2011 0.90
27 PHACES syndrome: a review. Int J Pediatr Otorhinolaryngol 2008 0.88
28 Asymptomatic inflammatory bowel disease presenting with mucocutaneous findings. Pediatrics 2005 0.88
29 PHACES association: a vasculocutaneous syndrome. Pediatr Cardiol 2008 0.88
30 Prospective study of the frequency of hepatic hemangiomas in infants with multiple cutaneous infantile hemangiomas. Pediatr Dermatol 2011 0.87
31 Neurodevelopmental abnormalities in children with PHACE syndrome. J Child Neurol 2012 0.86
32 Immunosuppressive effects in infants treated with corticosteroids for infantile hemangiomas. Arch Dermatol 2010 0.85
33 Familial nonmembranous aplasia cutis of the scalp. Pediatr Dermatol 2005 0.85
34 A comparison of disease severity among affected male versus female patients with PHACE syndrome. J Am Acad Dermatol 2007 0.84
35 Infantile hemangioma. Pediatr Clin North Am 2010 0.84
36 Candidate locus analysis for PHACE syndrome. Am J Med Genet A 2012 0.83
37 A case of ankyloblepharon, ectodermal dysplasia, and cleft lip/palate syndrome with ectrodactyly: are the p63 syndromes distinct after all? Pediatr Dermatol 2011 0.83
38 Histopathologic and immunophenotypic profile of subglottic hemangioma: multicenter study. Int J Pediatr Otorhinolaryngol 2009 0.83
39 Dermatologic manifestations of Crohn disease in children: response to infliximab. J Pediatr Gastroenterol Nutr 2003 0.82
40 Characteristics of infantile hemangiomas as clues to pathogenesis: does hypoxia connect the dots? Arch Dermatol 2010 0.82
41 Approach to the patient with an infantile hemangioma. Dermatol Clin 2013 0.81
42 Neonatal violaceous skin lesions: expanding the differential of the "blueberry muffin baby". Adv Dermatol 2005 0.80
43 Measuring the severity of infantile hemangiomas: instrument development and reliability. Arch Dermatol 2012 0.80
44 Copy number variation analysis in 98 individuals with PHACE syndrome. J Invest Dermatol 2012 0.79
45 Treatment of hemangiomas of infancy. Dermatol Ther 2005 0.79
46 Propranolol treatment of infantile hemangiomas: anticipatory guidance for parents and caretakers. Pediatr Dermatol 2013 0.78
47 Intertriginous eruption associated with chemotherapy in pediatric patients. Arch Dermatol 2007 0.78
48 Surgical treatment of infantile hemangioma in a multidisciplinary vascular anomalies clinic. Int J Pediatr Otorhinolaryngol 2011 0.78
49 What syndrome is this? Setleis syndrome. Pediatr Dermatol 2004 0.77
50 Diffuse neonatal hemangiomatosis: an evidence-based review of case reports in the literature. J Am Acad Dermatol 2012 0.77
51 Nevus simplex: a reconsideration of nomenclature, sites of involvement, and disease associations. J Am Acad Dermatol 2010 0.77
52 Microcystic adnexal carcinoma: the first reported congenital case. Pediatr Dermatol 2011 0.77
53 Risk of hepatic hemangiomas in infants with large hemangiomas. Arch Dermatol 2010 0.76
54 Inverse Gottron's papules: an unusual cutaneous manifestation of juvenile dermatomyositis. Pediatr Dermatol 2011 0.76
55 Propranolol use in PHACE syndrome with cervical and intracranial arterial anomalies: collective experience in 32 infants. Pediatr Dermatol 2012 0.76
56 Infantile hemangiomas: an update. Am J Clin Dermatol 2013 0.76
57 Twin nevus? Pediatr Dermatol 2005 0.75
58 Response to "Propranolol Induced Hypoglycemia" by Amir Horev, MD, Alon Haim, MD, Alex Zvulunov, MD. Pediatr Endocrinol Rev 2015 0.75
59 When good is not good enough: the predictive value of cutaneous lesions of the lumbosacral region for occult spinal dysraphism. Arch Dermatol 2004 0.75
60 Dramatic shift in the infantile hemangioma treatment paradigm at a single institution. Pediatr Dermatol 2013 0.75
61 Childhood lichen planus: demographics of a U.S. population. Pediatr Dermatol 2010 0.75
62 Large plantar mass in a newborn. Pediatr Dermatol 2006 0.75
63 Ventral midline blanching in the setting of segmental infantile hemangiomas: clinical observations and pathogenetic implications. Pediatr Dermatol 2014 0.75
64 Multiple congenital red-brown macules, thrombocytopenia, and gastrointestinal bleeding. Diagnosis: Multifocal lymphangioendotheliomatosis with thrombocytopenia (MLT). Pediatr Dermatol 2010 0.75
65 Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients. J Am Acad Dermatol 2008 0.75
66 Clear cell papulosis in Hispanic siblings. Arch Dermatol 2007 0.75
67 Pneumocystis carinii pneumonia in infant treated with oral steroids for hemangioma. Arch Dermatol 2007 0.75
68 Tooth enamel hypoplasia in PHACE syndrome. Pediatr Dermatol 2014 0.75
69 Spinal dysraphism associated with the cutaneous lumbosacral infantile hemangioma: a neuroradiological review. Pediatr Radiol 2011 0.75
70 Neural tube dysraphism: review of cutaneous markers and imaging. Pediatr Dermatol 2014 0.75
71 Cutaneous and disseminated blastomycosis: a pediatric case series. Pediatr Dermatol 2012 0.75
72 Erosive pustular dermatosis of the scalp after perinatal scalp injury. Pediatr Dermatol 2006 0.75
73 Association of hearing loss with PHACE syndrome. Arch Dermatol 2010 0.75
74 Endoscopic management of gastrointestinal bleeding from multifocal lymphangioendotheliomatosis with thrombocytopenia: limited efficacy and complications. J Pediatr Gastroenterol Nutr 2012 0.75
75 Risk of dysphagia and speech and language delay in PHACE syndrome. Pediatr Dermatol 2014 0.75
76 Expanding the phenotype of multifocal lymphangioendotheliomatosis with thrombocytopenia. Pediatr Blood Cancer 2009 0.75